ProfileGDS4718 / 1552349_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 52% 44% 48% 49% 50% 53% 48% 49% 50% 44% 38% 44% 62% 44% 46% 47% 65% 48% 42% 55% 45% 41% 44% 47% 61% 49% 50% 44% 50% 47% 42% 51% 46% 91% 92% 42% 50% 47% 43% 50% 63% 57% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3315347
GSM549102patient 115, normal, homogenized [OPG study]5.6337952
GSM549104patient 119, normal, homogenized [OPG study]5.1589844
GSM549108patient 138, normal, homogenized [OPG study]5.4305948
GSM549119patient 077, normal, homogenized [OPG study]5.4666849
GSM549133patient 032, cancer, homogenized [OPG study]5.4837950
GSM549139patient 042, cancer, homogenized [OPG study]5.6691953
GSM549099patient 107, normal, homogenized [OPG study]5.415648
GSM549109patient 139, normal, homogenized [OPG study]5.4865849
GSM549110patient 046, normal, homogenized [OPG study]5.5009450
GSM549114patient 063, normal, homogenized [OPG study]5.1401344
GSM549122patient 082, normal, homogenized [OPG study]4.8955338
GSM549134patient 033, cancer, homogenized [OPG study]5.1964544
GSM549136patient 036, cancer, homogenized [OPG study]6.2292962
GSM549140patient 044, cancer, homogenized [OPG study]5.1672844
GSM549111patient 047, normal, homogenized [OPG study]5.2522346
GSM549113patient 057, normal, homogenized [OPG study]5.2942947
GSM549132patient 031, cancer, homogenized [OPG study]6.4960665
GSM549137patient 038, cancer, homogenized [OPG study]5.3616448
GSM549142patient 047, cancer, homogenized [OPG study]5.2302442
GSM549100patient 110, normal, homogenized [OPG study]5.7899355
GSM549107patient 135, normal, homogenized [OPG study]5.2240745
GSM549115patient 068, normal, homogenized [OPG study]5.0022641
GSM549116patient 072, normal, homogenized [OPG study]5.1713744
GSM549120patient 078, normal, homogenized [OPG study]5.3530447
GSM549131patient 030, cancer, homogenized [OPG study]6.1964161
GSM549118patient 074, normal, homogenized [OPG study]5.4325449
GSM549129patient 027, cancer, homogenized [OPG study]5.5074450
GSM549123patient 088, normal, homogenized [OPG study]5.1555344
GSM549124patient 006, cancer, homogenized [OPG study]5.5135450
GSM549126patient 015, cancer, homogenized [OPG study]5.3505147
GSM549128patient 025, cancer, homogenized [OPG study]5.0664442
GSM549103patient 117, normal, homogenized [OPG study]5.6268151
GSM549117patient 073, normal, homogenized [OPG study]5.2595846
GSM549138patient 041, cancer, homogenized [OPG study]9.453191
GSM549141patient 045, cancer, homogenized [OPG study]9.5962992
GSM549130patient 028, cancer, homogenized [OPG study]5.1056442
GSM549101patient 111, normal, homogenized [OPG study]5.5442850
GSM549105patient 128, normal, homogenized [OPG study]5.3473447
GSM549106patient 134, normal, homogenized [OPG study]5.087543
GSM549112patient 048, normal, homogenized [OPG study]5.4870550
GSM549125patient 011, cancer, homogenized [OPG study]6.308663
GSM549127patient 024, cancer, homogenized [OPG study]5.9463857
GSM549135patient 035, cancer, homogenized [OPG study]5.2433646